SCHEMBL10288404

SCHEMBL10288404

N#Cc1c(N2CCOCC2)sc(C(=O)O)c1Cc1ccc2c(F)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.46
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
TRPV1 Q8NER1 3/20 0.37
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
PIK3R1 P27986 6/20 0.36
PIK3CD O00329 5/20 0.36
PIK3CB P42338 5/20 0.36
MTOR P42345 3/20 0.36
PIK3CG P48736 3/20 0.36
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
CYP3A4 P08684 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA4 P48058 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288586 0.91 PIK3CA (0.48) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL10006318 0.87 PIK3CA (0.51) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL10298714 0.85 PIK3CA (0.49) PIK3CAALDH1A1KDM4EHSD17B10FNTA
SCHEMBL10288327 0.85 PIK3CA (0.48) PIK3CAALDH1A1KDM4EHSD17B10FNTA
SCHEMBL10298530 0.84 TRPV1 (0.35) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL622915 0.84 PIK3CA (0.54) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL10308535 0.83 PIK3CA (0.54) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL10288156 0.82 PIK3CA (0.49) PIK3CAALDH1A1KDM4EHSD17B10HPGD
SCHEMBL623337 0.81 PIK3CA (0.58) PIK3CAALDH1A1HSD17B10FNTAFNTB
SCHEMBL10288606 0.81 PIK3CA (0.48) PIK3CAALDH1A1KDM4EHSD17B10FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885ALDH1A1 429/4885KDM4E 4086/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885ALDH1A1 429/4885KDM4E 4086/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885ALDH1A1 395/4885KDM4E 3971/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885ALDH1A1 395/4885KDM4E 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.